Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half‐Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study

Documenti analoghi

• Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome
  di: Pasquale Agosti, et al.
  Pubblicazione: (2024)
• Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging
  di: Roberta Gualtierotti, et al.
  Pubblicazione: (2024)
• Pathology of the Elbow in Haemophilia
  di: Hortensia De la Corte‐Rodriguez, et al.
  Pubblicazione: (2026)
• Qualification Criteria of Gene Therapy for Haemophilia—Opinion of the EAHAD Gene Therapy Working Group
  di: Wolfgang Miesbach, et al.
  Pubblicazione: (2025)
• Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry
  di: Kathelijn Fischer, et al.
  Pubblicazione: (2025)